Clinical Trial Assessing the Immunologic Response to a Influenza Vaccine Delivered Using an Jet Injection Device or a Needle Syringe

NCT01644149 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

83

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza Prophylaxis

Interventions

DEVICE: Stratis Jet Injector
DEVICE: Needle and Syringe
BIOLOGICAL: 2011-2012 Fluzone trivalent inactivated influenza vaccine

Sponsor

PharmaJet, Inc.